David A. Siegel Shattuck Labs, Inc. Transaction History
Two Sigma Advisers, LP
- $41.3 Billion
- Q4 2024
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Shattuck Labs, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 195,100 shares of STTK stock, worth $267,287. This represents 0.0% of its overall portfolio holdings.
Number of Shares
195,100
Previous 253,900
23.16%
Holding current value
$267,287
Previous $886,000
73.36%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding STTK
# of Institutions
74Shares Held
31.3MCall Options Held
0Put Options Held
0-
Prosight Management, LP Dallas, TX6.64MShares$9.1 Million2.39% of portfolio
-
Redmile Group, LLC San Francisco, CA5.54MShares$7.59 Million0.52% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA4.68MShares$6.4 Million0.01% of portfolio
-
Black Rock Inc. New York, NY2.47MShares$3.39 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.41MShares$3.3 Million0.0% of portfolio
About Shattuck Labs, Inc.
- Ticker STTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,382,000
- Market Cap $58.1M
- Description
- Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also develops SL-279252 that is ...